Videos

Imagine being sick and simply being able to ask your body what's going on and what it needs to get better. Well, the proteins in our body can tell us that. But it takes a long time for us to understand what they're saying. With his tool, QCquan.net, bioinformatician Joris Van Houtven is determined to speed up that process!

Did you know that being born with low birthweight (< 2.5 kg), increases the risk of a heart attack when you're 50 or older? Rossella Alfano (Uhasselt) examined 500 neonates and found out that babies with low birth weight have less HDL cholesterol, commonly known as 'good cholesterol'.

"Evolution is like a race: the individual who can reproduce the fastest wins the race. But we all know of one race that was not won by the fastest..." Jana Helsen (KU Leuven - VIB) explains how evolution is sometimes a bit like the fable about the tortoise and the hare.

"We must learn to talk about death, also in the workplace". Xenia Geysemans investigates how employers can better support grieving employees. Currently, employers are often too absent. In this video, Xenia offers 4 concrete tips.

In patients with Alzheimer's, microglia, the immune cells that protect our brains, suddenly start damaging the brain themselves by eating synapses. Ben Rombaut is trying to find out why this happens. In this way, he wants to help ensure that in our old age we can all stay on our toes.

People who had chickenpox as a child seem to be better protected against herpes zoster, better known as zona or shingles, at a later age. Using mathematic modeling, James Wambua (Hasselt University) is therefore investigating whether it is advisable to vaccinate children in Belgium against this childhood disease.

Immune cells serve to protect us. In multiple sclerosis, however, some immune cells just turn against the body and damage the nervous system. Sam Vanherle (Hasselt University) wants to detect these 'bad guys' in patients' blood and get them back on the right track. 💉

Did you know that there are already more than 15 medications for multiple sclerosis? Yet the more than 1 million progressive MS patients do not benefit from them, because these drugs only work in the early stages of the disease. Assia Tiane wants to help unravel the disease in order to improve the quality of life of progressive MS patients.

Cracking codes, it's a thing in escape rooms. But it is also what Bénedith Oben tries, albeit in the laboratory. In this way, she hopes to find the key to better understand the development of multiple myeloma, a common blood cancer.

How come medications have long leaflets with a whole list of possible side effects? That is what Hanne Leysen investigates. She looks at how signals are transmitted in our body, zooming in on cellular communication.

Marjolein Orije investigates whether vaccinating pregnant women helps to provide their child with the necessary antibodies against childhood diseases, such as whooping cough. Her research shows that vaccinating the pregnant mother also helps to boost the child's immune system, even if it is born prematurely.

It is a relatively new and promising path in cancer research: the reuse of old, non-cancer drugs. In her PhD, Laurie Freire Boullosa focuses on an old rheumatism pill and examines whether it can be used as a weapon against cancer.